First Time Loading...

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 31.82 CNY 1.73% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 30.64 CNY. Compared to the current market price of 31.82 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
30.64 CNY
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.1
P/S
P/S
Price to Sales
6.1
vs History
38
vs Industry
61
Median 3Y
6
Median 5Y
5.6
Industry
8.1
Forward
8.2
More Details
67.6
P/E
P/E
Price to Earnings
67.6
vs History
3
vs Industry
3
Median 3Y
42.2
Median 5Y
41
Industry
26.2
Forward
29.7
More Details
25
P/OCF
P/OCF
Price to OCF
25
vs History
33
vs Industry
7
Median 3Y
21.1
Median 5Y
20.4
Industry
22.6
More Details
29
P/FCFE
P/FCFE
Price to FCFE
29
vs History
42
vs Industry
6
Median 3Y
26.2
Median 5Y
26.2
Industry
21.3
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
84
vs Industry
41
Median 3Y
2.5
Median 5Y
3
Industry
2.5
More Details
4.1
EV/S
EV/S
Enterprise Value to Sales
4.1
vs History
84
vs Industry
58
Median 3Y
4.5
Median 5Y
4.7
Industry
7.3
Forward
5.5
More Details
7.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.7
vs History
71
vs Industry
48
Median 3Y
8.4
Median 5Y
8.3
Industry
9.1
More Details
19.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.7
vs History
92
vs Industry
7
Median 3Y
27.6
Median 5Y
26.5
Industry
4.4
Forward
14.9
More Details
19.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.7
vs History
92
vs Industry
7
Median 3Y
27.6
Median 5Y
26.5
Industry
4.3
Forward
17
More Details
16.8
EV/OCF
EV/OCF
Enterprise Value to OCF
16.8
vs History
41
vs Industry
9
Median 3Y
15
Median 5Y
15
Industry
5.4
More Details
19.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.5
vs History
41
vs Industry
7
Median 3Y
18.7
Median 5Y
16.8
Industry
3.2
More Details
4.4
EV/IC
EV/IC
Enterprise Value to IC
4.4
vs History
25
vs Industry
35
Median 3Y
4.2
Median 5Y
3.8
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
16B CNY 6.1 67.6 19.7 19.7
US
Abbvie Inc
NYSE:ABBV
280.4B USD 5.2 58.2 12.7 19.3
US
Amgen Inc
NASDAQ:AMGN
146.3B USD 5.2 21.7 16.2 24.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 10.3 28.2 22.6 23.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.9B USD 7.5 24.8 16.4 18
AU
CSL Ltd
ASX:CSL
132.9B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
82.8B USD 3.1 14.6 8 10.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.6B USD 6.2 -9 -9.6 -8.2
US
Biogen Inc
NASDAQ:BIIB
31.6B USD 3.2 27.2 14.7 18.2
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.